What Should Specialty Pharmacists Know About the ReDOS Clinical Trial?


Tanios Bekaii-Saab, MD, FACP, Mayo Clinic Cancer Center, talks about key takeaways from the phase 2 ReDOS clinical trial for specialty pharmacists.

Related Videos
Image Credit: Adobe Stock - nataliaderiabina
Credit: Adobe Stock - Tierney
ipopba - stock.adobe.com
lexiconimages - stock.adobe.com
Yaruniv-Studio - stock.adobe.com
Credit: Karanov images - stock.adobe.com
Technician- © pharmacytimes
Related Content
© 2023 MJH Life Sciences

All rights reserved.